John J. Sheehan, PhD, MBA, RPh

Ravi Potluri ;

David Rotter ;

Harsh Kuvadia ;

Association of Depression Severity With Acute Risk of ER Visits and Hospitalizations Among Adults With Major Depressive Disorder

Anandaroop Dasgupta , PhD, MS;

11/22/2019

Introduction: Although major depressive disorder (MDD) is the leading cause of disability worldwide, the relationship between depression severity and risk of ER visit/hospitalization is u...

Wenze Tang , PhD, MPH, MS;

Kun Wang , PhD;

US Mental Health Resource Utilization in Major Depressive Disorder With Suicidal Ideation

Christopher D. Pericone , PhD;

11/22/2019

Introduction: Major depressive disorder (MDD) and suicidal ideation/behavior, both incur substantial mental health resource utilization (MHRU) burden, yet little is known of the burden of...

Kun Wang , PhD;

Harsh Kuvadia ;

Is Increased Severity of Major Depressive Disorder Associated With Incremental Economic Burden in Privately Insured US Patients With Treatment Resistant Depression?

Jacqueline Pesa , PhD, MPH;

Nancy Connolly , MPH;

11/22/2019

Background: Among patients with major depressive disorder (MDD), those with treatment-resistant depression (TRD) have a higher economic burden. However, healthcare resource utilization (H...

Laura Morrison , MPH;

Patrick Lefebvre , MA;

Prevalence of Pre-existing Conditions for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies among Patients with Treatment-Resistant Depression

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

Holly Szukis , MPH;

Maryia Zhdanava , MA;

03/01/2019

BACKGROUND: Comorbidities complicate clinicians' efforts to manage major depressive disorder (MDD). Pre-existing conditions and drug-drug interactions (DDI) may limit the array of safe ph...

Leslie Citrome , MD;

Laura Morrison , MPH;

Budget Impact Analysis of Esketamine Nasal Spray in a Sub-Population of Adults With Major Depressive Disorder and High Unmet Need: Payer Perspective in the United States

Carmine Rossi , PhD;

Maryia Zhdanava , MA;

Oliver Lopena , PharmD;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

Swapna Karkare , MS;

10/19/2020

Background: Esketamine nasal spray (ESK) plus comprehensive standard of care (SOC) vs placebo plus SOC was studied in two phase 3 antidepressant clinical trials among a sub-population of ...

Hoa Le , PhD;

Hector Toro-Diaz , PhD;

Shujun Li , MS;

National Trends in the Prevalence of Major Depressive Disorder With Suicidal Ideation Among Adults Using National Survey on Drug Use and Health Data

10/08/2020

Introduction: Although depression is a known risk factor for suicide, little is known about how the prevalence of co-occurring major depressive disorder (MDD) and suicidal ideation/behavi...

Kun Wang , PhD;

Harsh Kuvadia ;